CIRM Funded Clinical Trials

RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration

Investigator:
Institution:
CIRM Grant:
CLIN2-15282 (Active)
Award Value:
$4,009,675.00
Trial Sponsor:
Luxa Biotechnology
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov